U.S. Solicitor General Wants Supreme Court to Reject Reglan Lawsuit Appeal

By Jack Simony

The U.S. Solicitor General wants to the U.S. Supreme Court to reject an appeal by drug companies in a generic Reglan lawsuit filed over a claim about failing to adequately warn about a rare movement order associated with the drug, AboutLawsuits reported. 

“The court of appeals correctly held that respondent’s failure-to-warn claims are not categorically preempted, because a generic manufacturer, can (and indeed, must) inform FDA of new information about risks that may require a change in the labeling of its drug,” the Solicitor General stated, according to the website.

- By Jack Simony